Ignite Creation Date:
2025-12-25 @ 2:45 AM
Ignite Modification Date:
2026-04-14 @ 6:18 PM
Study NCT ID:
NCT00991133
Status:
COMPLETED
Last Update Posted:
2015-04-30
First Post:
2009-10-05
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Safety and Tolerability Study of Clofarabine, Etoposide, Cyclophosphamide, PEG-asparaginase, and Vincristine in Pediatric Acute Lymphoblastic Leukemia (ALL)
Sponsor:
Genzyme, a Sanofi Company